MUC5B and COVID-19: It is essential to highlight that this is the first study where this variant is analyzed in patients without a previous diagnosis of IPF, in addition to being the first study where plasma concentrations of mucin 5B are reported for patients with severe COVID-19 who were carriers of the allele risk (rs35705950/T).